Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.7248
+0.172531.23%
Post-market: 0.75000.0252+3.48%19:59 EDT
Volume:5.42M
Turnover:3.67M
Market Cap:60.72M
PE:-0.24
High:0.7789
Open:0.5600
Low:0.5600
Close:0.5523
Loading ...
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 18, 2023

Correspondence

Form CORRESP - Correspondence
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 11, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Aug 25, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Major Issues Report

Form 8-K - Current report